Status:

COMPLETED

Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery

Lead Sponsor:

Stanford University

Conditions:

Major Depressive Disorder

Surgery

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

This study evaluates whether ketamine, given as part of an anesthetic, improves depression symptoms in depressed patients undergoing non-cardiac surgery. Half of participants will receive a ketamine i...

Detailed Description

Major Depressive Disorder (MDD) is widely prevalent among patients preparing to have surgery, and is a known risk factor for complications after surgery, including wound infection, myocardial infarcti...

Eligibility Criteria

Inclusion

  • Patient presenting for non-cardiac, non-intracranial surgery
  • Major Depressive Disorder

Exclusion

  • Pregnant of breastfeeding women

Key Trial Info

Start Date :

August 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 27 2022

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT03861988

Start Date

August 22 2019

End Date

September 27 2022

Last Update

October 5 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94305